Commercial mouthwashes are more effective than azole antifungals against Candida albicans biofilms in vitro

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 111, Issue 4, 2011, Pages 456-460

  Ramage, Gordon ^a   Jose, Anto ^a   Coco, Brent ^a   Rajendran, Ranjith ^a   Rautemaa, Riina ^b,c   Murray, Colin ^a   Lappin, David F ^a   Bagg, Jeremy ^a  

^a GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ECHINOCANDIN; MOUTHWASH; NON PRESCRIPTION DRUG; POLYENE; PYRROLE DERIVATIVE;

ARTICLE; BIOFILM; CANDIDA ALBICANS; CHEMISTRY; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DRUG EFFECT; EVALUATION; HUMAN; METABOLISM; MICROBIOLOGICAL EXAMINATION; NONPARAMETRIC TEST; PLANKTON;

ANTIFUNGAL AGENTS; AZOLES; BIOFILMS; CANDIDA ALBICANS; CHI-SQUARE DISTRIBUTION; ECHINOCANDINS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOUTHWASHES; NONPRESCRIPTION DRUGS; PLANKTON; POLYENES; STATISTICS, NONPARAMETRIC;

EID: 79952986494     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2010.10.043     Document Type: Article

References (31)

1. B.J. Coco, J. Bagg, L.J. Cross, A. Jose, J.G. Cross, and G. Ramage Mixed Candida albicans and Candida glabrata populations associated with the pathogenesis of denture stomatitis Oral Microbiol Immunol 23 2008 377 383
2. L.A. Drage, and R.S. Rogers 3rd Burning mouth syndrome Dermatol Clin 21 2003 135 145 (Pubitemid 36255256)
3. G. Ramage, E. Mowat, B. Jones, C. Williams, and J. Lopez-Ribot Our current understanding of fungal biofilms Crit Rev Microbiol 35 2009 340 355
4. M.A. Al-Fattani, and L.J. Douglas Penetration of Candida biofilms by antifungal agents Antimicrob Agents Chemother 48 2004 3291 3297 (Pubitemid 39129321)
5. M.A. Al-Fattani, and L.J. Douglas Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance J Med Microbiol 55 2006 999 1008 (Pubitemid 44215557)
6. P. Perumal, S. Mekala, and W.L. Chaffin Role for cell density in antifungal drug resistance in Candida albicans biofilms Antimicrob Agents Chemother 51 2007 2454 2463 (Pubitemid 47047324)
7. G. Ramage, S. Bachmann, T.F. Patterson, B.L. Wickes, and J.L. Lopez-Ribot Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms J Antimicrob Chemother 49 2002 973 980 (Pubitemid 34692891)
8. J. Bagg, M.P. Sweeney, M.A. Lewis, M.S. Jackson, D. Coleman, and M.A. Al High prevalence of non-Albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer Palliat Med 17 2003 477 481 (Pubitemid 37160885)
9. D. Wray, E.W. Battison, T. Coia, A. Crighton, and M.P. Sweeney Drug prescribing for dentistry: dental clinical guidance Scottish Dental Clinical Effectiveness Programme (SDCEP). Dundee 2008
10. L.J. Cross, D.W. Williams, C.P. Sweeney, M.S. Jackson, M.A. Lewis, and J. Bagg Evaluation of the recurrence of denture stomatitis and Candida colonization in a small group of patients who received itraconazole Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97 2004 351 358 (Pubitemid 38326664)
11. T.C. White Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus Antimicrob Agents Chemother 41 1997 1482 1487 (Pubitemid 27289672)
12. Clinical Laboratory Standards Institute CLSI reference method for broth dilution antifungal susceptibility testing of yeast; approved standardthird edition CLSI document M27-A3 2008
13. G. Ramage, K. vande Walle, B.L. Wickes, and J.L. Lopez-Ribot Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms Antimicrob Agents Chemother 45 2001 2 475-9
14. S.P. Hawser, and L.J. Douglas Resistance of Candida albicans biofilms to antifungal agents in vitro Antimicrob Agents Chemother 39 1995 2128 2131
15. C.G. Pierce, P. Uppuluri, A.R. Tristan, F.L. Wormley Jr, E. Mowat, and G. Ramage A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing Nat Protoc 3 2008 1494 1500
16. A. Jose, B.J. Coco, S. Milligan, B. Young, D.F. Lappin, and J. Bagg Reducing the incidence of denture stomatitis: are denture cleansers sufficient? J Prosthodont 19 2010 252 257
17. T. Pereira-Cenci, A.A. del Bel Cury, W. Crielaard, and J.M. ten Cate Development of Candida-associated denture stomatitis: new insights J Appl Oral Sci 16 2008 86 94
18. G. Ramage, K. VandeWalle, J.L. Lopez-Ribot, and B.L. Wickes The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans FEMS Microbiol Lett 214 2002 95 100 (Pubitemid 35245528)
19. A.M. Tortorano, A. Prigitano, E. Biraghi, M.A. Viviani European Confederation of Medical Mycology Survey of candidaemia in Italy: in vitro susceptibility of 375 Candida albicans isolates and biofilm production J Antimicrob Chemother 56 2005 777 779 (Pubitemid 41487784)
20. K. Niimi, B.C. Monk, A. Hirai, K. Hatakenaka, T. Umeyama, and E. Lamping Clinically significant Micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity J Antimicrob Chemother 65 2010 842 852
21. M.J. Jacobson, K.E. Steckelberg, K.E. Piper, J.M. Steckelberg, and R. Patel In vitro activity of Micafungin against planktonic and sessile Candida albicans isolates Antimicrob Agents Chemother 53 2009 2638 2639
22. G. Garcia-Effron, S. Lee, S. Park, J.D. Cleary, and D.S. Perlin Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint Antimicrob Agents Chemother 53 2009 3690 3699
23. M. Castanheira, L.N. Woosley, D.J. Diekema, S.A. Messer, R.N. Jones, and M.A. Pfaller Low prevalence of fks1 hotspot 1 mutations in a worldwide collection of Candida spp Antimicrob Agents Chemother 54 2010 Nos.: 2655-9
24. T.F. Meiller, J.I. Kelley, M.A. Jabra-Rizk, L.G. Depaola, A.A. Baqui, and W.A. Falkler Jr In vitro studies of the efficacy of antimicrobials against fungi Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91 2001 663 670 (Pubitemid 33601681)
25. H. Lamfon, S.R. Porter, M. McCullough, and J. Pratten Susceptibility of Candida albicans biofilms grown in a constant depth film fermenter to chlorhexidine, fluconazole and miconazole: a longitudinal study J Antimicrob Chemother 53 2004 383 385 (Pubitemid 38239979)
26. G. Giuliana, G. Pizzo, M.E. Milici, G.C. Musotto, and R. Giangreco In vitro antifungal properties of mouthrinses containing antimicrobial agents J Periodontol 68 1997 729 733 (Pubitemid 27357900)
27. S. Shapiro, E. Giertsen, and B. Guggenheim An in vitro oral biofilm model for comparing the efficacy of antimicrobial mouthrinses Caries Res 36 2002 93 100
28. I. Tomas, M.C. Cousido, L. Garcia-Caballero, S. Rubido, J. Limeres, and P. Diz Substantivity of a single chlorhexidine mouthwash on salivary flora: influence of intrinsic and extrinsic factors J Dent 38 2010 Nos.: 541-6
29. D. Conway Oral health, mouthwashes and cancerwhat is the story? Evid Based Dent 10 2009 6 7
30. C. La Vecchia Mouthwash and oral cancer risk: an update Oral Oncol 45 2009 198 200
31. J. Bagg, M.S. Jackson, M. Petrina Sweeney, G. Ramage, and A.N. Davies Susceptibility to Melaleuca alternifolia (tea tree) oil of yeasts isolated from the mouths of patients with advanced cancer Oral Oncol 42 2006 487 492